Prenatal Intravenous Magnesium at 30-34 Weeks’ Gestation and Neurodevelopmental Outcomes in Offspring

Overview of attention for article published in JAMA: Journal of the American Medical Association, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 22 news outlets
blogs: 6 blogs
twitter: 152 X users

facebook: 1 Facebook page
guideline: 1 clinical guideline source
podcasts: 4 podcasts

Readers on

mendeley: 97 Mendeley

So far, Altmetric has seen 157 X posts from 152 X users, with an upper bound of 944,177 followers.

Paper 3/ MAGENTA trial Magsulph at 30-34w TL/DR: NO benefit for child survival free of cerebral palsy at 2yr age Reduced RDS & chronic lung disease ‼️ Trial was underpowered so ? change our local guideline for magsulph if using magsulph for >30w …

https://t.co/zbb7eq0k0v

RT @JezidMiranda: https://t.co/IkL6Gg4VAL

https://t.co/IkL6Gg4VAL

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 153 additional X posts.